Apr 8, 2018 | Featured, Research News, Technology Updates
Eli Lilly ponies up $63M for Sigilon’s diabetes cell therapies, according to Amirah Al Adrus of FierceBiotech.com, 4 April 2018. Eli Lilly is continuing its push into new diabetes products, paying $63 million up front to get its hands on Sigilon Therapeutics’...
Apr 2, 2018 | Recommended Books
Well, the title tagline says it all: A Survival Guide. “Here is a given: 100% of people do not like having diabetes. Most partners don’t wish to burden anyone with their disease 1, especially not their significant other. Often, the...